GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » USCOM Ltd (ASX:UCM) » Definitions » Total Liabilities

USCOM (ASX:UCM) Total Liabilities : A$3.87 Mil (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is USCOM Total Liabilities?

USCOM's Total Liabilities for the quarter that ended in Dec. 2023 was A$3.87 Mil.

USCOM's quarterly Total Liabilities increased from Dec. 2022 (A$1.90 Mil) to Jun. 2023 (A$2.14 Mil) and increased from Jun. 2023 (A$2.14 Mil) to Dec. 2023 (A$3.87 Mil).

USCOM's annual Total Liabilities declined from Jun. 2021 (A$2.26 Mil) to Jun. 2022 (A$2.06 Mil) but then increased from Jun. 2022 (A$2.06 Mil) to Jun. 2023 (A$2.14 Mil).


USCOM Total Liabilities Historical Data

The historical data trend for USCOM's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

USCOM Total Liabilities Chart

USCOM Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 2.50 2.26 2.06 2.14

USCOM Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.21 2.06 1.90 2.14 3.87

USCOM Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

USCOM's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.215+(0.829+0.053
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.039)
=2.14

Total Liabilities=Total Assets (A: Jun. 2023 )-Total Equity (A: Jun. 2023 )
=5.18-3.044
=2.14

USCOM's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.99+(0.779+0.105
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=3.87

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=6.025-2.151
=3.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


USCOM Total Liabilities Related Terms

Thank you for viewing the detailed overview of USCOM's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


USCOM (ASX:UCM) Business Description

Traded in Other Exchanges
N/A
Address
Level 8, 66 Clarence Street, Suite 2, Sydney, NSW, AUS, 2000
USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimizing respiratory device performance.

USCOM (ASX:UCM) Headlines

No Headlines